54 346 (Lithium Carbonate Extended Release 450 mg)
Pill with imprint 54 346 is White, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Roxane Laboratories, Inc..
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; schizoaffective disorder; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 346
Lithium Carbonate Extended Release
- Imprint:
- 54 346
- Strength:
- 450 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Roxane Laboratories, Inc.
- Inactive Ingredients:
- ferrosoferric oxide
magnesium stearate
povidone
sodium alginate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0655 | Amerisource Health Services |
More about lithium
- Lithium Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 280 Reviews
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Lithium
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Capsules and Tablets
- Lithium Syrup and Oral Solution
- Lithium (Advanced Reading)
Other brands: Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
